|
|
Gene Symbol |
LEP |
|
Aliases |
LEPD, OB, OBS |
|
Entrez Gene ID |
|
|
Gene Name |
Leptin |
|
Chromosomal Location |
7q32.1 |
|
HGNC ID |
|
|
Summary |
This gene encodes a protein that is secreted by white adipocytes into the circulation and plays a major role in the regulation of energy homeostasis. Circulating leptin binds to the leptin receptor in the brain, which activates downstream signaling pathways that inhibit feeding and promote energy expenditure. This protein also has several endocrine functions, and is involved in the regulation of immune and inflammatory responses, hematopoiesis, angiogenesis, reproduction, bone formation and wound healing. Mutations in this gene and its regulatory regions cause severe obesity and morbid obesity with hypogonadism in human patients. A mutation in this gene has also been linked to type 2 diabetes mellitus development. [provided by RefSeq, Aug 2017]
|
|
RefSeq DNA |
|
|
RefSeq mRNA |
|
|
e!Ensembl
|
Protein Information |
|
Protein Name |
Leptin, leptin (murine obesity homolog), leptin (obesity homolog, mouse), obese protein, obese, mouse, homolog of, obesity factor |
|
Function |
Key player in the regulation of energy balance and body weight control. Once released into the circulation, has central and peripheral effects by binding LEPR, found in many tissues, which results in the activation of several major signaling pathways (PubMed:17344214, PubMed:15899045, PubMed:19688109). In the hypothalamus, acts as an appetite-regulating factor that induces a decrease in food intake and an increase in energy consumption by inducing anorexinogenic factors and suppressing orexigenic neuropeptides, also regulates bone mass and secretion of hypothalamo-pituitary-adrenal hormones. In the periphery, increases basal metabolism, influences reproductive function, regulates pancreatic beta-cell function and insulin secretion, is pro-angiogenic for endothelial cell and affects innate and adaptive immunity (By similarity) (PubMed:8589726, PubMed:11460888, PubMed:19688109, PubMed:24340098, PubMed:25060689). In the arcuate nucleus of the hypothalamus, activates by depolarization POMC neurons inducing FOS and SOCS3 expression to release anorexigenic peptides and inhibits by hyperpolarization NPY neurons inducing SOCS3 with a consequent reduction on release of orexigenic peptides (By similarity). In addition to its known satiety inducing effect, has a modulatory role in nutrient absorption. In the intestine, reduces glucose absorption by enterocytes by activating PKC and leading to a sequential activation of p38, PI3K and ERK signaling pathways which exerts an inhibitory effect on glucose absorption (PubMed:24340098). Acts as a growth factor on certain tissues, through the activation of different signaling pathways increases expression of genes involved in cell cycle regulation such as CCND1, via JAK2-STAT3 pathway, or VEGFA, via MAPK1/3 and PI3K-AKT1 pathways (By similarity) (PubMed:17344214). May also play an apoptotic role via JAK2-STAT3 pathway and up-regulation of BIRC5 expression (PubMed:18242580). Pro-angiogenic, has mitogenic activity on vascular endothelial cells and plays a role in matrix remodeling by regulating the expression of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) (PubMed:11460888). In innate immunity, modulates the activity and function of neutrophils by increasing chemotaxis and the secretion of oxygen radicals. Increases phagocytosis by macrophages and enhances secretion of pro-inflammatory mediators. Increases cytotoxic ability of NK cells (PubMed:12504075). Plays a pro-inflammatory role, in synergy with IL1B, by inducing NOS2 wich promotes the production of IL6, IL8 and Prostaglandin E2, through a signaling pathway that involves JAK2, PI3K, MAP2K1/MEK1 and MAPK14/p38 (PubMed:15899045, PubMed:19688109). In adaptive immunity, promotes the switch of memory T-cells towards T helper-1 cell immune responses (By similarity). Increases CD4(+)CD25(-) T-cell proliferation and reduces autophagy during TCR (T-cell receptor) stimulation, through MTOR signaling pathway activation and BCL2 up-regulation (PubMed:25060689). |
|
|
|
|
|
UniProt |
|
|
PDB |
|
|
Pfam |
Pfam Accession |
Pfam ID |
PF02024 |
Leptin |
|
|
|
|
Interactions |
| |
STRING |
MINT |
IntAct |
ENSP00000249075 |
P15018 |
P15018 |
|
| |
View interactions
|
|
| |
Associated Diseases
Disease group | Disease Name | References |
Cardiovascular Diseases |
Hypertensive disease |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
Atonic seizures |
|
Digestive System Diseases |
Gastric ulcer |
|
Fatty Liver |
|
Non-alcoholic Fatty Liver Disease |
|
Enteritis |
|
Colitis |
|
Oral ulcer |
|
Crohn Disease |
|
Endocrine System Diseases |
Hypogonadism |
|
Diabetes Mellitus |
|
Leptin Deficiency |
|
PCOS |
|
Immune System Diseases |
Autoimmune Hepatitis |
|
Neoplasms |
Colonic Neoplasms |
|
Breast Cancer |
|
Prostate cancer |
|
Ovarian Cancer |
|
Nervous System Diseases |
Seizures |
|
Jacksonian Seizure |
|
Nutritional and Metabolic Diseases |
Obesity |
15070752, 9500540, 9202122, 25551525, 17517446, 19913045, 20122948, 9502777, 25086370, 24042701, 25554529, 9826672, 23839791, 26186301, 28698385, 18515891 |
Hyperinsulinism |
|
Metabolic Syndrome X |
|
Hypercholesterolemia |
|
Gluocose Intolerance |
|
Psychiatric/Brain disorders |
Autistic Disorder |
|
Schizophrenia |
|
Mental Depression |
|
Alzheimer Disease |
|
Senile Dementia |
|
Psychosis |
|
Non-organic psychosis |
|
Eating Disorders |
|
Obstructive Sleep Apnea |
|
Reproductive disorders |
Subfertility, Female |
|
Preeclampsia |
|
|
References |
|
|
|
PubMed ID |
Associated gene/s |
Associated condition |
Genetic Mutation |
Diagnostic Criteria |
Association with PCOS |
Ethnicity |
Conclusion |
|
|
PCOS, |
|
|
Related
|
34 PCOS women, 30 controls |
The results of this study showed that serum leptin levels in a subgroup of overweight women with PCOS and insulin resistance were higher than those expected for their BMI, and therefore leptin might interfere in the pathogenesis of PCOS |
|
|
PCOS |
|
|
Related
|
20 eumenorrheic controls (10 lean [group A] and 10 overweight [group B]) and 24 PCOS women (14 lean [group C] and 10 overweight [group D]) |
Leptin was lower in the lean groups as compared to the overweight group |
|
Ghrelin, testosterone, immune-reactive insulin (IRI), sex hormone-binding globulin, dehydroepiandrosterone sulfate, cortisol, LH and FSH |
PCOS |
|
|
Related
|
45 women with PCOS and 20 controls |
Serum leptin levels have a strong correlation with clinical and hormonal indices of IR |
|
Ghrelin, testosterone, immune-reactive insulin (IRI), sex hormone-binding globulin, cortisol, luteinizing hormone and follicle-stimulating hormone |
PCOS |
|
|
Related
|
45 PCOS, 20 controls |
The ghrelin level in women with PCOS reflects the metabolic and hormonal changes which are characteristics of the syndrome. The inverse correlation between ghrelin and leptin in these women is mediated through metabolic factors. |
|
Serum visfatin, adiponectin, sex hormone levels |
PCOS |
|
|
Related
|
73 PCOS patients, 75 controls |
Patients withPCOS have high visfatin and leptin levels but low adiponectin levels |
|
Adiponectin, interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-alpha) |
PCOS |
|
|
Related
|
86 ( 60 PCOS, 26 controls) |
The higher levels of leptin and TNF-alpha, the lower level of adiponectin in obese PCOS and the higher level of TNF-alpha and IL-6 in non-obese PCOS suggested different adipocytokines play different roles of insulin resistance in PCOS |
|
Adiponectin, RBP4 |
PCOS |
|
Rotterdam criteria |
Related
|
57 women with PCOS (27 obese & 30 nonobese) and 27 controls |
Young obese women with PCOS have increased ADMA, RBP4, and leptin levels |
|
|
PCOS |
Pro12Ala PPAR 2 gene polymorphism |
|
Related
|
54 PCOS women and 51 healthy women |
The PCOS women had higher leptin and NPY levels and lower galanin levels. Obese PCOS patients had lower CCK levels |
|
Adiponectin |
PCOS |
|
|
Related
|
Bahraini women |
In Bahraini women with PCOS, insulin, L/A, and A/L ratios seem to be the best markers to distinguish women with and withoutPCOS |
|
Adiponectin |
PCOS, obesity |
|
|
Related
|
|
Serum leptin levels are found to be higher in people suffering from PCOS |
|
Adiponectin |
PCOS |
|
Diagnosis of the novel phenotype required the presence of 3 diagnostic features including: 1) a personal history of oligomenorrhea; 2) history of infertility or miscarriage; 3) current or past clinical or hormonal evidence of hyperandrogenism; 4) central |
Related
|
713 post menopausal women |
Serum leptin was found to be higher in patients suffering from PCOS |
|
Adiponectin |
PCOS |
|
|
Related
|
168 (92 daughters of PCOS women, 76 controls) |
Leptin and adiponectin may be related to metabolic and reproductive abnormalities observed in PCOSd during the early stages of sexual development |
|
Adiponectin |
PCOS |
|
|
Related
|
88 (31 women with PCOS, 57 controls) |
Serum leptin was higher in overweight/obese patients with PCOS than in all normal-weight control women |
|
|
PCOS |
|
|
Related
|
|
The results of this reveal that leptin levels are elevated in women with PCOS and associate with BMI |
|
Kisspeptin, RBP4 |
PCOS |
|
Rotterdam criteria |
Related
|
90 (54 women with PCOS and 36 controls) |
The findings of this study suggest that kisspeptin, leptin, and RBP4 are associated with metabolic disturbances in women with PCOS |
|
Adiponectin, insulin, M llerian-inhibiting substance, luteinizing hormone, follicle-stimulating hormone, testosterone, 17-alpha-hydroxyprogesterone, androstendione, dehydroepiandrosterone sulphate (DHEAS), 17beta-oestradiol |
PCOS |
|
|
Related
|
44 (14 were overweight [body mass index (BMI) standard deviation score >1.645] with PCOS; 16 were lean (BMI SDS <1.036) with PCOS; and 14 were lean (BMI SDS <1.036) without PCOS) |
Leptin levels were significantly elevated in obese adolescents with PCOS compared with the levels in normal weight adolescents with PCOS, and compared with that in normal weight controls |
|
Anthropometrics, cortisol, DHEAS, glucose, insulin |
PCOS |
|
|
Related
|
30 PCOS patients |
PCOS patients responding to OGTT were obese and had high leptin |
|
Testosterone, immune-reactive insulin (IRI), sex hormone-binding globulin, cortisol, LH and FSH |
PCOS |
|
|
Related
|
45 women with PCOS, 20 controls |
Serum leptin levels in PCOS patients were higher than in the control group independently of BMI, WHR and waist circumference |
|
|
PCOS |
|
|
Related
|
21 with unexplained infertility 28 with polycystic ovary syndrome (PCOS), 30 with bilateral tubal occlusion, and 33 with endometriosis, |
This study hypothesized that leptin may be an active factor in the pathogenesis of PCOS and endometriosis |
|
|
PCOS |
R482W, R482Q, R439C on LMNA |
|
Related
|
7 families ( 14 affected, 34 controls) |
Mean blood leptin level was significantly lower in LMNA-mutated patients than in nonaffected relatives. In these LMNA-linked lipodystrophic patients, the prevalence of PCOS, infertility, and gestational diabetes was higher than in the general population |
|
LH, FSH, E2, testosterone, and androstenedione |
PCOS |
|
|
Related
|
91 patients with PCOS |
LH secretion in PCOS patients can be viewed as a consequence of the activity of different adipocyte and neuroendocrine factors. The attenuation in basal LH levels in obese PCOS women might be related to a leptin-resistant state |
|
sex hormone-binding globulin |
PCOS |
|
|
Related
|
74 Greek women with PCOS (38 normal-weight and 36 overweight-obese women) |
The Adiponectin/Leptin ratio may serve as a biomarker of both insulin resistance and low-grade inflammation, providing the link between these cardiovascular risk factors in women with PCOS. |
|
Insulin, insulin-antibody, testosterone, estrogen, and progestogen |
PCOS |
|
|
Related
|
20 PCOS and 20 controls |
Peritoneal fluid and serum leptin concentration and insulin,T, Ins-antibody level are abnormal in PCOS patients. Leptin may play an important role in the pathogenesis of PCOS. BMI is the main factor to correlate with leptin |
|
|
PCOS, subclinical eating behaviour (SEB) |
|
|
Related
|
154 (77 pairs of Iranian twins (96 Monozygotic individuals and 58 Dizygotic individuals )) |
Leptin is linked with both subclinical eating disorder andPCOS |
|
|
PCOS, obesity |
|
|
Related
|
122 PCOS women, 81 controls |
PCOS patients had higher leptin levels |
|
|
PCOS, Hyperandrogenism |
|
|
Related
|
20 girls with premature adrenarche, 21 postmenarcheal girls with hirsutism, 26 controls |
Higher leptin levels in adolescents with hyperandrogenism than in healthy girls show possible involvement of leptin in pathogenesis of hyperandrogenism |
|
|
PCOS |
|
|
Related
|
46 caucasian women with PCOS, 46 caucasian controls |
Leptin levels, although higher among obese cases, were not statistically different than those in controls |
|
|
PCOS |
|
|
Related
|
224 (74 PCO, 150 controls) |
PCO women ovaries showed higher expression of leptin as compared to controls |
|
|
PCOS |
|
NIH criteria |
Related
|
11 PCOS, 9 controls |
In PCOS women there is abrogation of the regularity of monohormonal leptin secretory patterns, despite normal mean serum leptin concentrations |
|
|
PCOS, Hirsuitism |
|
Adams et al., 1986, Herter et al., 1996 |
Related
|
27 women with PCOS, 20 controls with idiopathic hirsutism |
Leptin concentrations were significantly higher in obese PCOS women than in normal weight women with either PCOS or IH |
|
|
PCOS, Obesity |
|
|
Related
|
20 PCOS patients |
The study infers that by increased intrafollicular leptin levels, obesity directly affects ovarian function in PCOS |
|
|
PCOS |
|
The diagnosis of PCOS was based on typical ovarian morphology assessed by transvaginal ultrasonography, hyperandrogenism (i.e. elevated total or free testosterone or androstenedione concentrations), and chronic anovulation |
Related
|
38 Finnish PCOS patients, 122 controls |
The study concludes that leptin and LEPR mutants do not cause PCOS |
|
|
PCOS |
|
|
Related
|
28 women with PCOS, 32 obese women (non-PCOS) and 19 lean healthy women (control group) |
The results of this study indicate that the feedback system in the interaction between leptin and NPY may be disturbed in PCOS |
|
insulin, testosterone, SHBG, FSH, LH, and prolactin |
PCOS |
|
|
Related
|
27 obese PCOS patients, 18 non obese PCOS patients, 20 obese and non obese controls |
Leptin concentrations were significantly higher in PCOS women than in controls |
|
|
PCOS, obesity |
|
|
Related
|
23 obese women with PCOS, 16 obese controls, 10 non-obese controls |
The findings of this study indicate that leptin levels in obese women with PCOS are higher than those observed in obese and non-obese controls |
|
|
PCOS, insulin sensitivity, obesity |
|
|
Related
|
22 PCOS women, 19 controls |
The study concluded that high serum leptin, insulin and testosterone levels together with reduced insulin sensitivity were found in obese PCOS women, suggesting their role in obese PCOS phenotype |
|
|
PCOS, insulin sensitivity, obesity |
|
|
Related
|
58 women with PCOS and 70 controls |
The results of this study indicated that abnormalities in leptin signaling to the reproductive system may be involved in certain cases of PCOS |
|
|
|
|